Drug interactions
Fostemsavir + Triptorelin
Severity: Minor
Fostemsavir and Triptorelin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Fostemsavir causes QT prolongation only at supratherapeutic exposures, while triptorelin may modestly lengthen the QT interval. Risk at recommended doses is small but may matter with other risk factors.
What this interaction means in plain words
Fostemsavir and Triptorelin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Fostemsavir belongs to Anti Virals; Triptorelin belongs to Endocrine.
Why it happens
Possible additive QT prolongation.
What to do
Check ECG in patients with known QT prolongation, cardiac disease or other QT-prolonging drugs. Avoid combining with strong CYP3A inducers or inhibitors that change fostemsavir exposure unnecessarily.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Fostemsavir and Triptorelin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Triptorelin
Other interactions of Fostemsavir
- Apalutamide + Fostemsavir Contraindicated
- Carbamazepine + Fostemsavir Contraindicated
- Enzalutamide + Fostemsavir Contraindicated
- Fostemsavir + Mitotane Contraindicated
- Fostemsavir + Phenytoin Contraindicated
- Fostemsavir + Rifampicin Contraindicated
Frequently asked questions
Can I take Fostemsavir with Triptorelin?
MediHelp rates the interaction as minor. Fostemsavir and Triptorelin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fostemsavir causes QT prolongation only at supratherapeutic exposures, while triptorelin may modestly lengthen the QT interval. Risk at recommended doses is small but may matter with other risk factors.
How serious is the interaction between Fostemsavir and Triptorelin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check ECG in patients with known QT prolongation, cardiac disease or other QT-prolonging drugs. Avoid combining with strong CYP3A inducers or inhibitors that change fostemsavir exposure unnecessarily.
What other medicines interact with Triptorelin?
MediHelp also lists interactions of Triptorelin with, for example, Amisulpride, Arsenic trioxide, Bedaquiline. The full list is on the Triptorelin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
